Omega-3 Market Projected to Reach $8.73 billion by 2031 | Top Companies are Pelagia and Aker BioMarine

Omega-3 Market by Type (DHA, EPA, & ALA), Source (Marine & Plant), Application (Dietary Supplements, Functional Foods & Beverages, Pharmaceuticals, Infant Formulas, and Pet Food & Feed), Form, Manufacturing Technology, and Region - Global Forecast to 2031
According to MarketsandMarkets Trademark , the [https://www.marketsandmarkets.com/Market-Reports/omega-3-omega-6-227.html] is projected to grow from USD 4.88 billion in 2026 to reach USD 8.73 billion by 2031, at a Compound Annual Growth Rate (CAGR) of 12.3% during the forecast period. The demand for omega-3 is expected to increase significantly with a consumer group that is increasingly becoming more aware of the benefits of supporting cardiovascular, cognitive, and eye health. Where other nutrients, omega-3 fatty acids, an example being EPA and DHA, cannot be synthesized efficiently by the human body, resulting in increased reliance on nutritional supplements, fortified foods, and pharmacy-grade preparations. Omega-3 oils can also be added to capsules, powders, drinks, and functional foods, specified for stability and effectiveness. Fish oil, krill oil, and algal-based omega-3 are the most favorite sources, with scientific verification for their safety and efficacy. The increasing acceptance among a growing number of health-oriented consumers, as well as the rising popularity of products based on clean labels and sustainability, is likely to cause a further boost to the outlook for the omega-3 market in the years ahead.

Image: https://mnmimg.marketsandmarkets.com/Images/omega-3-omega-6-img-overview.webp

Market Size and Forecast:

* Market Size Value in 2025: USD 4.36 Billion
* Market Size Value in 2026: USD 4.88 Billion
* Revenue Forecast in 2031: USD 8.73 Billion
* Growth Rate: CAGR of 12.3% from 2026 to 2031
* Data available from 2022 to 2031
* Base year: 2025
* Forecast period: 2026-2031
* North America is estimated to account for the largest market share of 37% in 2026, driven by rising demand for omega-3 products.
* The marine source segment is estimated to dominate with a market share of 93.6% in 2026.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=227

By type, the DHA segment is to exhibit the fastest growth rate during the forecast period.

Docosahexaenoic acid (DHA), a polyunsaturated omega-3 fatty acid (PUFA), is widely distributed throughout the body and has emerged as the leading type segment in the omega-3 market. It serves as a significant structural fat present in both the brain and eye, constituting as much as 97% of the total omega-3 fats in the brain and up to 93% in the retina. The main sources of DHA are fish, fish oils, dairy products, and specialty eggs, with marine sources such as salmon and tuna being particularly rich. Farmed salmon contains about 1.24 g of DHA, and wild salmon about 1.22 g of DHA.

Additionally, DHA is a crucial component of cardiac tissue and is also commonly referred to as 22:6(n-3). Direct consumption of DHA is necessary to effectively increase fatty acid levels in the body, and optimal intake is crucial for both infant brain development and normal adult brain function. Epidemiological research further associates healthy DHA intake with a reduced risk of Alzheimer's disease, as DHA improves communication between nerve cells and membranes by enhancing fluidity. Its critical role in visual and neurological development in infants, coupled with widespread applications in infant nutrition, dietary supplements, and functional foods, has solidified DHA as the dominating segment within the omega-3 market. The growing demand from both developed and emerging economies ensures that DHA continues to hold a substantial market share compared to other omega-3 types, such as EPA and ALA.

By application, the infant formulas segment to record the highest CAGR during forecast period.

The infant formulas segment is anticipated to grow at a significant rate in the omega-3 market due to the rising recognition of DHA's crucial role in infant brain and eye development. DHA, often referred to as the "brain-building" omega-3, is recommended by leading health authorities such as the World Health Organization (WHO) and the European Food Safety Authority (EFSA) for inclusion in infant nutrition. With an increasing number of working mothers and a higher reliance on formula feeding, demand for fortified infant formulas containing DHA and EPA has surged worldwide. Manufacturers are consistently innovating by introducing premium formulas that mimic the fatty acid composition of human breast milk, further boosting adoption. Regulatory mandates in many regions, such as the EU's requirement since 2020 for DHA inclusion in all infant formula and follow-on formula products, have led to the European Union (EU) implementing new regulations, effective February 22, 2021, regarding the recommended DHA supplementation in healthy diets. These regulations mandate that all infant formula and follow-on formula available for purchase within the EU must contain a minimum of 20 mg/100 kcal (or 4.8 mg/100 kJ) and a maximum of 50 mg/100 kcal (or 128 mg/100 kJ) of DHA, which is accelerating market growth. In addition, growing consumer preference for organic and clean-label formulas, along with strong demand in emerging economies driven by rising birth rates and improved purchasing power, is expected to fuel the segment's expansion during the forecast period.

Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=227

Europe accounts for significant share of global omega-3 market.

Europe is expected to hold a significant share of the omega-3 market, driven by a robust regulatory framework, high consumer awareness, and a growing preference for preventive healthcare. Additionally, European consumers show a higher inclination toward premium dietary supplements and clean-label products, fostering demand for sustainable fish oil and plant/algal-based omega-3 alternatives. The presence of major global players, continuous research and development initiatives, and widespread adoption of fortified foods and beverages further strengthen Europe's dominance. Moreover, increasing vegetarian and flexitarian populations in countries such as Germany, the UK, and France are accelerating the demand for algal-derived omega-3, ensuring steady market growth across the region. According to the European Food Safety Authority (EFSA), micronutrients present in omega-3s even benefit eye and brain health, which has led to heavy focus and a surge in consumption among Europeans. Companies such as Pelagia AS (Norway), Corbion (Netherlands), and DSM-Firmenich (Netherlands) are the key players that are highly focused on catering to the demand for omega-3-based products in the European region. In 2023, several recent advancements were observed in the omega-3 market within the European region. Corbion (Netherlands) launched a new product, AlgaVia, whereas Pelagia AS (Norway) invested in its production facility to increase the output of the omega-3 concentrates.

The European Society of Cardiology (ESC) has had a significant impact on the omega-3 market in the European region, as its studies emphasize that omega-3 consumption helps decrease the risk of cardiovascular diseases. European omega-3 manufacturers are investing in omega-3 applications, such as dietary supplements, functional food & beverages, and pharmaceuticals. BASF SE (Germany) offers microencapsulated omega-3 powder with more shelf life to cater to the European demand. Furthermore, the rise in consumer awareness has prompted manufacturers to follow and adhere to European regulations, which is projected to drive growth in Europe.

Leading [https://www.marketsandmarkets.com/ResearchInsight/omega-3-omega-market.asp?utm_source=prnewswire.com&utm_medium=paidpr&utm_campaign=omega-3-market]:

The report profiles key players such as BASF SE (Germany), Cargill, Incorporated (US), DSM-Firmenich (Netherlands), ADM (US), Kerry Group plc (Ireland), Aker BioMarine (Norway), Croda International plc (UK), Corbion (Netherlands), Pelagia AS (Norway), KD Pharma Group SA (Switzerland), GC Rieber (Norway), Cooke Aquaculture Inc. (Canada), GOLDEN OMEGA (Chile), Polaris (France), Btsa (Spain), KinOmega Biopharm Inc. (China), Rimfrost AS (Norway), Mara Renewables (Canada), Cellana Inc. (US), and AlgaeCytes Limited (UK).

Recent Developments in the [https://www.marketsandmarkets.com/PressReleases/omega-3.asp]:

* April 2026: DSM-Firmenich launched Veramaris O3 Max Pure at Petfood Forum 2026, introducing the world's first microalgal omega-3 oil with the same natural 3:2 EPA:DHA ratio as high-quality fish oil. The product was designed as a non-GMO, vegan, and sustainable fish oil replacement for pet food formulations.
* April 2026: Fermentalg launched OMEGA ohm RIGINS EPA/DHA, a next-generation microalgae-derived omega-3 oil featuring the industry's first naturally achieved 40% EPA and 20% DHA (400/200) ratio without any concentration process. Produced using a patented fermentation technology and proprietary Schizochytrium strain, the product would deliver up to 60% total omega-3 content and is targeted at dietary supplements, functional foods & beverages, and pet nutrition.
* July 2025: Corbion received regulatory approval in China for its algae-based omega-3 solutions, marking a significant milestone in its global expansion strategy. These omega-3 ingredients, derived from microalgae, were designed for use in nutritional supplements, functional foods, and beverages, offering a sustainable and plant-based alternative to traditional fish oil. The approval enabled Corbion to enter one of the world's largest and fastest-growing markets for health and wellness products, reinforcing its commitment to innovation and environmental responsibility in the nutraceutical sector.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=227

About MarketsandMarkets Trademark

MarketsandMarkets Trademark has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets Trademark is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines - TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore Trademark , which integrates research and provides ecosystem-wide visibility into revenue shifts.

Media Contact
Company Name: MarketsandMarkets Trademark Research Private Ltd.
Contact Person: Mr. Rohan Salgarkar
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=omega3-market-projected-to-reach-873-billion-by-2031-top-companies-are-pelagia-and-aker-biomarine]
Phone: 18886006441
Address:1615 South Congress Ave. Suite 103, Delray Beach, FL 33445
City: Florida
State: Florida
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/omega-3-omega-6-227.html

Legal Disclaimer: Information contained on this page is provided by an independent third-party content provider. ABNewswire makes no warranties or responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you are affiliated with this article or have any complaints or copyright issues related to this article and would like it to be removed, please contact retract@swscontact.com



This release was published on openPR.